Earnings Releases·Nov 4, 2026, 7:56 PM ET

LifeStance Health Group, Inc. — Q3 2026 Earnings Summary

Q3 2026 revenue reached $455.9 million, up 25% year-over-year, while net income surged to $22.4 million from $1.1 million in the prior-year period; adjusted EBITDA rose 70% to $68.4 million (15.0% of revenue).
Management raised full-year 2026 guidance across all key metrics: revenue to $1.741–$1.761 billion, center margin to $599–$613 million, and adjusted EBITDA to $242–$250 million.
The company repurchased $122.4 million of common stock over the first nine months of 2026, while clinician headcount grew 11% year-over-year to 8,863 and visit volumes increased 17% to 2.7 million.
Strategic investments include the implementation of a new Electronic Health Record (EHR) system and $9.6 million in acquisitions, supported by strong operating leverage and $22.4 million in third-quarter free cash flow.